Company ProfilePremium

Unilever Plc

Company Profile Analysis

Ticker: ULVR.L

ESOMAR 23 Corporate BadgeISO Certifications Badge
Unilever Plc - Food & Beverages showcase

Year Founded & Workforce

1929

96,000 Employees

Industry

Food & Beverages
Unilever Plc logo

Unilever Plc Employee Contacts

645 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Unilever Plc Overview

ItemDetail
Entity profiledUnilever PLC (parent of the Unilever Group)
Listing statusPublic, listed (matches the type supplied)
Websitewww.unilever.com
Country of incorporationEngland and Wales (United Kingdom)
Former names / structureIncorporated in 1894 as Lever Brothers Limited; later Unilever Limited, then Unilever PLC. From 1930 to November 2020 the Group operated a dual-parent structure (Unilever PLC in the UK and Unilever N.V. in the Netherlands); Unification under the single parent Unilever PLC completed on 29 November 2020
Founding yearUnilever formed by the merger of Lever Brothers (UK, founded 1885) and Margarine Unie (Netherlands) in 1929, effective 1 January 1930
Headquarters100 Victoria Embankment, London EC4Y 0DY, United Kingdom (Form 20-F 2025)
Stock exchanges and tickersLondon Stock Exchange: ULVR; Euronext Amsterdam: UNA; New York Stock Exchange: UL (American Depositary Shares, one ADS = one ordinary share)
ISINLegacy ordinary-share ISIN GB00B10RZP78; market data sources show GB00BVZK7T90 following the December 2025 share consolidation (confirm with registrar)
CUSIP (ADS)904767704 (legacy)
SEC file number001-04546 (Form 20-F filer, large accelerated filer)
Fiscal year end31 December
AuditorKPMG LLP (London); H1 2026 review report signed by Jonathan Downer, 27 July 2026
Ordinary shares outstanding2,181,005,247 at 31 December 2025 (Form 20-F 2025); a further 30,703,780 shares were repurchased between 30 April and 5 June 2026
Employees (latest)c.96,000 (continuing operations, Form 20-F 2025)
Market capitalisation (current)≈ £100bn (≈ €115bn) — share price 4,664.5p on 25 September 2026 × c.2.15bn shares; eToro reported ≈ £101bn in the same period. Analyst-computed; not an official company figure
Credit ratingsS&P A+ / A-1 (outlook negative); Moody's A1 / P-1 (outlook stable) — company debt-investor page
MetricFY2023FY2024FY2025
Employees (approx., thousands)12812896

FY2023 and FY2024 figures are the c.128,000 headcount cited by Unilever and media at the launch of the productivity programme in March 2024 (pre-restructuring, including Ice Cream). FY2025 is the continuing-operations figure after the Ice Cream demerger and the 7,500-role productivity programme (c.6,000 roles removed by Q1 2025). The FY2024 year-end figure on a like-for-like basis was not separately verified.

Unilever is one of the world's three largest fast-moving consumer goods groups by revenue, with €50.5bn of continuing turnover in FY2025, brands used by an estimated 3.7 billion people daily and products sold in around 190 countries. Following the December 2025 demerger of Ice Cream and the March 2026 agreement to combine its Foods business with McCormick, Unilever is in the middle of the most radical portfolio reshaping in its history: it is converging on a pure-play Home and Personal Care (HPC) company with pro-forma revenue of roughly €39bn, anchored in Beauty & Wellbeing, Personal Care and Home Care. Its competitive edge rests on 30 Power Brands (78% of turnover), an unmatched emerging-markets footprint (59–60% of turnover), and scale in India and the United States. The investment debate now centres on whether Unilever can sustain volume-led growth of 4–6% and close its valuation gap with US HPC peers.


What the company does

Unilever develops, manufactures, markets and distributes branded consumer goods across four Business Groups. Its own description in the Form 20-F 2025 characterises it as "a global consumer goods business with a strong category focus and differentiated capabilities." The Group organises its commercial activity around its top 24 markets, grouped into eight geographies and accounting for around 85% of turnover; the remaining smaller and mid-sized markets are run under a lean "One Unilever" (1UL) model in which each market manages its own P&L.

Business model

Unilever's model is that of a branded manufacturer: it captures value through brand equity (pricing power and mix), innovation (formulation science, sensorials, formats), scale procurement and manufacturing, and route-to-market reach that extends from global e-commerce platforms and modern trade to millions of small traditional retailers in emerging markets. The value-creation plan disclosed in the Form 20-F 2025 is explicit: absolute profit growth consistent with a top-third total shareholder return (TSR) ambition, driven by volume growth and gross-margin expansion, with roughly 100% cash conversion, around 2x net debt/underlying EBITDA, strong single-A credit ratings, high-teens underlying ROIC, a dividend payout ratio of around 60% and buybacks funded from surplus cash. Management has ruled out transformational M&A in favour of bolt-ons.

Revenue model

Revenue typeApproximate shareCommentary
Product sales (branded consumer goods)≈ 97–99%Virtually all turnover is product revenue sold to retailers, distributors, wholesalers and e-commerce platforms
Professional/foodservice salesEmbedded in FoodsUnilever Food Solutions (UFS) sells ingredients to restaurants and caterers; exact share not disclosed
Direct-to-consumer / subscriptionSmall, not disclosedNutrafol (hair-growth supplements) and some prestige brands operate subscription and DTC models; share not disclosed
Services / licensingMinorTransitional Services Agreement fees from TMICC (IT, marketing, co-packing, invoicing) recognised in operating profit for up to two years from December 2025; brand licensing not material

The split above is an analyst characterisation; Unilever does not disclose a product/service/subscription breakdown.

Value chain position, customers and end-markets

Unilever sits in the middle of the value chain: it buys agricultural commodities (palm oil and its derivatives, soybean oil, vegetables, tea, dairy), petrochemical derivatives (surfactants, plastics) and packaging, and sells finished goods to customers. It is increasingly vertically integrating in surfactants, fragrance and some key materials (Home Care), and in-housing production for premium brands such as Liquid I.V. (around half of production in-housed per the Form 20-F 2025).

Customer types include global and national grocery multiples (e.g., Walmart, where Dove x Crumbl is distributed across more than 4,000 stores), drugstore and beauty specialists (Ulta Beauty for Nutrafol and prestige brands), e-commerce platforms (Amazon, quick-commerce in India and China), cash-and-carry and wholesale, millions of small-format traditional retailers in India and Indonesia (served partly through AI-enabled ordering apps), salons and professional channels (K18, Dermalogica), and foodservice operators (UFS). End-markets are hair care, skin care, prestige beauty, vitamins/minerals/supplements (VMS), deodorants, skin cleansing, oral care, fabric cleaning and enhancers, household cleaning and hygiene, cooking aids, condiments and professional foodservice.

Independent characterisation

Unilever is in transition from a diversified food-and-HPC conglomerate to a focused HPC group with a premium and emerging-markets bias. The Ice Cream demerger (December 2025) and the Foods/McCormick combination (expected to close by mid-2027) together remove roughly 40% of the 2024 group revenue base. What remains is a portfolio that is structurally faster-growing (Beauty & Wellbeing and Personal Care grew 4.3% and 4.7% respectively in FY2025) but historically lower-margin in Home Care (14.9% underlying operating margin in FY2025). The strategic logic is coherent and supported by recent execution, but investors should recognise that the post-Foods Unilever will lose its highest-margin Business Group: Foods earned a record 22.6% underlying operating margin in FY2025.

Strategy

Stated strategy (Annual Report 2025 and investor communications)

The strategic framework disclosed in the Form 20-F 2025 rests on a value-creation ambition of absolute profit growth consistent with top-third TSR, driven by volume growth and gross-margin expansion. It is delivered through three fundamental shifts:

  1. Desire at Scale (brands): "SASSY" brands built on Science, Aesthetics, Sensorials, being Shared by others and Young-spirited; plus a "frontline machine" for marketing and sales execution across every channel.

  2. Play to Win (people): a performance culture with differentiated reward and an uncompromising stance on talent.

  3. Fit for the AI Age (organisation): AI and technology deployed across creativity, growth and margin, together with productivity and simplicity.

These are focused on seven strategic growth priorities: Beauty, Wellbeing and Personal Care (categories); Premium (proposition); Digital Commerce (channel); and the United States and India (geographies). Sustainability (climate, nature, plastics, livelihoods) is positioned as an underpinning rather than a headline strategy, a notable shift from the Sustainable Living Plan era.

Strategic initiatives in the last 24 months

InitiativeTimingDetail and targetsStatus
Productivity programmeLaunched March 2024€800m savings; c.7,500 roles affected; separation of Ice Cream-related stranded costsCompleted ahead of plan by H1 2026 (€670m achieved by end-2025)
Ice Cream demergerMarch 2024–December 2025TMICC listed 8 December 2025; 19.85% retained, to be sold down within about five yearsCompleted; TSA runs up to December 2027
Foods combination with McCormickAnnounced 31 March 2026Reverse Morris Trust; $15.7bn cash; Unilever shareholders 55.1% and Unilever 9.9% of the combined company; ~$600m cost synergies by year threeExpected completion by mid-2027 at the latest
Category-dedicated sales forces2,025Separate Business Group sales organisations in each of the top 24 marketsImplemented
Indonesia and China resets2,025Route-to-market and portfolio changesBoth returned to growth in H2 2025 and grew in H1 2026
Latin America corrective actionsH2 2025Price-gap restoration in Brazil Home Care; deodorant format-mix changesBrazil double-digit growth in Q2 2026
Social-first marketing and AI content studios2025–2026Beauty AI Studio, Personal Care AI Studio (four markets), Sketch Pro (Home Care), Brand DNAi governance framework; tripling of creator content for Dove USScaling in 2026
Fragrance capability€100m announced 2024In-house fragrance design; first in-house Dove fragrance launched in 2025Ongoing
FIFA World Cup 2026 sponsorshipJune–July 2026Official Personal Care Sponsor; Rexona official deodorantActivated; supported Q2 2026 volumes
Portfolio pruning2025–202610 transactions closed or announced since start of 2025Ongoing
Capital returns2026–2029€6bn total buybacks over 2026–2029 supported by McCormick cash; €1.5bn completed June 2026In progress

Net-zero operational emissions (Scope 1 and 2) by 2030 versus 2015; Scope 3 energy and industrial emissions -42% and FLAG emissions -30.3% by 2030 versus 2021; virgin plastic footprint -30% by 2026 and -40% by 2028 versus 2019; and regenerative agriculture on 1m hectares by 2030. Unilever will review the scope and baselines of these goals in 2026 after the Ice Cream demerger.

Medium-term guidance

MetricGuidance
Underlying sales growthMulti-year range of 4% to 6%
Underlying volume growthAt least 2% (FY2026 upgraded to around 3%)
Underlying operating marginModest improvement annually, fuelled by gross margin
Cash conversionAround 100% over time
LeverageAround 2x net debt / underlying EBITDA; strong single-A ratings
ROICHigh teens
Dividend payoutAround 60% of underlying EPS
M&ABolt-on only; no transformational M&A

Products & Services

Unilever does not disclose brand-level revenue, launch-year data for most lines, or pricing. The catalog below is organised brand by brand from the Form 20-F 2025 and FY2025/H1 2026 results; launch years are given only where disclosed.

Beauty & Wellbeing

BrandCategoryDescription and flagship offeringsTarget customerLatest disclosed innovation / yearPricing model
Dove (hair and skin)Hair Care / Skin CareMass-premium hair and skin care; renovated hair range using Bio-Protein Care / fibre-repair technology rolled out across eight markets including US, India and BrazilMass and masstige consumers globallyRenovated hair care range, 2025Retail, mass-premium
SunsilkHair CareMass hair care strong in emerging markets; double-digit growth in Q2 2026Emerging-market mass consumers—Mass retail, sachets
ClearHair CareAnti-dandruff scalp-care brandEmerging markets, men and women—Mass retail
TRESemméHair CareSalon-inspired mass hair care; improving in US in H1 2026Mass consumers—Mass retail
NexxusHair CareSalon-quality premium hair carePremium US consumers—Premium retail
K18Prestige hairBiotech peptide-based hair repair; HeatBounce leave-in heat protectantPrestige and salon consumersHeatBounce, 2025 (acquired 2024)Prestige, salon and retail
VaselineSkin CarePetroleum-jelly-based skin protection, lotions; double-digit growth for three consecutive years; #VaselineVerified social campaign (Cannes Titanium Lion)Mass globalPremium innovations 2025–2026Mass retail
Pond'sSkin CareFacial skin care, strong in AsiaMass/masstige Asia—Mass retail
DermalogicaPrestige Skin CareProfessional skin care sold through skin therapists and retailProfessional and prestigeReturned to growth H2 2025Prestige, professional
Paula's ChoicePrestige Skin CareActives-led skin care, DTC heavyIngredient-savvy consumersStrong Q2 2026Prestige, DTC
HourglassPrestige CosmeticsLuxury colour cosmeticsPrestigeStrong double-digit growth 2025Prestige
TatchaPrestige Skin CareJapanese-inspired luxury skin carePrestigeStrong Q2 2026Prestige
Minimalist (via HUL)Skin Care (India)Premium, actives-led beauty brand; 90.5% acquired April 2025Urban Indian consumersAcquired 2025Digital-first, premium
NutrafolWellbeing (VMS)Hair-growth supplements; number-one dermatologist-recommended hair-growth supplement in US; turnover tripled since 2022 acquisition; Ulta Beauty retail expansion and MLB partnership; positioning as a complement to GLP-1 regimensConsumers with hair thinningUlta expansion, 2025Subscription/DTC and retail
Liquid I.V.Wellbeing (VMS)Electrolyte hydration multiplier; sugar-free range (first launched US 2023) extended to three markets including China; launch in India; sugar-free energy lineActive, health-conscious consumersIndia launch, energy line 2025Retail and e-commerce
OLLYWellbeing (VMS)Gummy vitamins and supplements; premium gummy innovationMass-premium US consumersPremium gummies 2025Retail
GrünsWellbeing (VMS)US greens supplement leader; acquired June 2026Health-conscious US consumersAcquired 2026DTC / subscription (company characterisation not disclosed)
RENPrestige Skin CareClosure announced 2025 (€42m impairment)—Discontinued—
Kate SomervillePrestige Skin CareDivested November 2025—Divested—

Personal Care

BrandCategoryDescription and flagship offeringsTarget customerLatest disclosed innovation / yearPricing model
Dove / Dove Men+CareSkin Cleansing, DeodorantsSerum Shower Collection with MicroMoisture technology (launched 2024 in North America, India late 2025); Whole Body Deodorant (US launch 2024); Dove x Crumbl limited editions; first in-house fragrance (Garden Tea Party)Mass-premium globalSerum Body Wash; Whole Body Deo; 2024–2025Mass-premium retail
Rexona / Degree / SureDeodorantsAntiperspirants; Whole Body formats; official deodorant sponsor of FIFA World Cup 2026; "The Locker Room" social hubMass, sports-orientedFIFA 2026 activationsMass retail
Axe / LynxDeodorants, Body WashFragrance-led male grooming; gourmand variants (Cherry Spritz, Sunset Fresh)Gen Z males2025 limited editionsMass retail
LuxSkin CleansingFragrance-led beauty soap and body wash; new fragrance range in ChinaMass Asia2,026Mass retail
LifebuoySkin CleansingGerm-protection soap and hand wash; flat in 2025 due to commodity-led price risesMass emerging markets—Mass retail
CloseupOral CareToothpaste; Closeup White Now whitening using stain-control science across AsiaYoung consumers in Asia2,025Mass retail
PepsodentOral CareToothpaste; premium naturals and whitening rangesMass Asia2,025Mass retail
SignalOral CareEuropean/Latin toothpaste brand (not a Power Brand)Mass—Mass retail
Dr. SquatchPersonal Care (men's natural)Natural soap, deodorant and grooming; 98.7% acquired September 2025 for €1,243mUS millennial/Gen Z menAcquired 2025DTC and retail
WildPersonal Care (natural, refillable)Refillable deodorants, lip balm, body and hand wash; 100% acquired April 2025Sustainability-minded consumersAcquired 2025DTC subscription and retail

Home Care

BrandCategoryDescription and flagship offeringsTarget customerLatest disclosed innovation / yearPricing model
Dirt Is Good (Persil, OMO, Skip, Surf Excel, Breeze)Fabric CleaningLaundry powders, liquids and capsules; Wonder Wash for short, cold cycles (launched 2024), now in 30 markets including India and BrazilMass and premium householdsWonder Wash 2024–2026Mass retail
SurfFabric CleaningValue-tier laundry brandValue-seeking households—Mass retail
Brilhante (Brazil)Fabric CleaningBrazilian laundry brandBrazilian households—Mass retail
Comfort / FofoFabric EnhancersFabric conditioners, boosters; premium formats and fragrance-led innovationMass/premiumBoosters 2025Mass retail
CifHome & HygieneSurface cleaners; Cif Infinite Clean probiotic multi-purpose spray with 72-hour action (launched 2025, five European markets); reusable trigger spray (UK)Households in Europe, LatAm, Asia2,025Mass-premium retail
DomestosHome & HygieneToilet and bleach-based hygieneMass globalPremium innovations 2025Mass retail
SunlightDishwash / LaundryDishwash and laundry bars and liquids; probiotic tech in VietnamMass emerging markets—Mass retail
RadiantFabric CleaningLaundry brand (primarily Asia)Mass Asia—Mass retail
VimHome & HygieneDishwash; extended into adjacent cleaning in India; probiotic variantsIndian households—Mass retail
WipolHome & HygieneIndonesian floor/surface cleaner with probiotic technologyIndonesian households—Mass retail

Foods (to be combined with McCormick, excluding India and certain other territories)

Brand / offeringCategoryDescription and flagship offeringsTarget customerLatest disclosed innovation / yearPricing model
KnorrCooking Aids & Mini MealsBouillons, seasonings, soups, ready-to-heat pots, air-fryer cooking pastes (UK, Germany)Home cooks globallyAir-fryer pastes, 2025Mass retail
Hellmann's / Best FoodsCondimentsMayonnaise and flavoured mayo (range reached €100m across 35 markets), squeeze formats in Brazil; US competition in premium and avocado mayoHouseholdsFlavoured mayo; 2025Mass retail
Horlicks (via HUL)Health Food DrinksMalted health drink, double-digit growth in India H1 2026; remains with Unilever (India excluded from the McCormick perimeter)Indian families2026 innovationMass retail
Unilever Food SolutionsProfessional foodserviceKnorr Professional (incl. Seasoned Soy Sauce, China), Hellmann's foodservice; Future Menus programme with chefs in 50+ markets; largest markets China and USRestaurants, caterers2,025B2B distribution
Colman's, Marmite, Pfanni, Mondamin, Unox, ZwanLocal foods brandsLocal heritage brands; binding offers received for Unox and Zwan (2025)Local markets—Mass retail
Divested since 2025—Conimex (to Paulig, April 2025), The Vegetarian Butcher (September 2025), Graze (February 2026), Indonesia tea/Sariwangi (March 2026)———

Brand-level pricing is not publicly disclosed for any Unilever brand.

Financial Narrative

Headline P&L — as originally reported (FY2021–FY2024 include Ice Cream; FY2025 is continuing operations unless labelled)

Notes and sources: Turnover and attributable net profit from Unilever FY results as compiled by MarketScreener and confirmed against company releases for FY2023–FY2025. FY2025 total net profit and attributable profit include the €3,373m tax-exempt gain on the Ice Cream demerger; FY2025 net profit from continuing operations was €6,213m (€5,682m attributable). FY2025 diluted EPS is the continuing-operations figure after the 8-for-9 consolidation; total-operations diluted EPS was €4.32. FY2024 total net profit (€6,369m) is as re-stated in the FY2025 accounts and is consistent with the €6.4bn originally reported. Underlying EBITDA for FY2021–FY2024 is from MarketScreener (company-based); FY2025 is per the FY2025 Results. Free cash flow: FY2021 and FY2024 rounded from company disclosures (€6.4bn; €6.9bn as originally reported, €6.3bn continuing); FY2022 (€5.2bn) and FY2023 (€7.1bn) per the FY2023 Results. Net debt FY2021–FY2023 from aggregator data consistent with company definitions; MarketScreener reports different values (FY2021 25510; FY2022 23676; FY2023 23657) — discrepancy noted; primary filings should be consulted. Dividends: quarterly declarations of €0.4268 through Q1 2024, €0.4396 for Q2–Q3 2024, €0.4528 for Q4 2024–Q3 2025 and €0.4664 from Q4 2025 (company dividend history).

Continuing-operations P&L (re-presented)

Gross profit is derived as gross margin × turnover. FY2024 gross margin is inferred from the 20bps improvement reported for FY2025. Source: FY2025 Results, Form 20-F 2025.

Revenue CAGR. On an as-reported basis turnover fell from €52.4bn (FY2021) to €50.5bn (FY2025), a CAGR of about -0.9%, but this is distorted by the removal of Ice Cream (≈€7.7–8.3bn a year), the tea disposal and currency. A more meaningful indicator is cumulative underlying sales growth: compounding the reported USG of 4.5%, 9.0%, 7.0%, 4.2% and 3.5% gives about 31% over five years, overwhelmingly price-led in 2022–2023 and volume-led since 2024. Currency translation was severely adverse (-5.9% in FY2025 alone, driven by Latin American currencies, the Indian rupee, the US dollar and the Turkish lira).

Commentary. The five-year record divides into two phases. In 2021–2023, Unilever navigated a commodity super-cycle by pricing aggressively (UPG of 6.8% in FY2023 on the original basis), which protected revenue but crushed volumes (0.2% in FY2023) and compressed margins: underlying operating margin fell from 18.4% (FY2021) to 16.7% (FY2022, originally reported). From late 2023, under the Growth Action Plan and then the Fernandez agenda, the model inflected towards volume growth, gross-margin rebuild (continuing gross margin 46.9% in FY2025) and a step-up in brand investment (BMI up roughly 300bps over four to five years to 16.1%). Underlying operating margin reached a record 20.0% in FY2025 on a continuing basis, helped by the removal of lower-margin Ice Cream and €670m of productivity savings. The key weakness is that reported profit and EPS growth have been neutralised by currency: underlying EPS rose only 0.7% in FY2025 despite constant-currency profit growth, with an 8.8% adverse currency effect.

Balance sheet

The FY2025 decline in goodwill, PP&E and equity reflects the Ice Cream demerger: carrying net assets of €4.0bn were derecognised and a non-cash dividend of €6,752m was recorded against retained earnings. The retained 19.85% stake in TMICC was carried at €1,655m (fair value through OCI) at 31 December 2025. Source: FY2025 Results; 2026 First Half Results.

Cash flow

FY2025 cash conversion was 100% (FY2024: 104%). FY2025 FCF fell €0.4bn mainly due to tax on disposals linked to the Ice Cream demerger. Unilever expects around 100% cash conversion again in FY2026.

Key ratios

Calculations: FY2025 ROE uses continuing attributable profit (€5,682m) to exclude the demerger gain; FY2024 uses total attributable profit (€5,744m). FY2024 net debt/EBITDA uses the continuing UEBITDA; Unilever originally reported 1.9x including Ice Cream. FY2024 asset turnover mixes a continuing turnover figure with balance-sheet assets that still included Ice Cream, and is therefore understated. At H1 2026 net debt/underlying EBITDA rose to 2.3x (rolling twelve months), driven by dividends and the €1.5bn buyback; management guides to around 2x for FY2026.

Cash conversion cycle: not publicly disclosed. A derived calculation is not meaningful because the FY2025 receivables and payables are grossed up by the TMICC transitional services arrangement and "trade payables and other current liabilities" includes non-trade items. Indicatively, inventory days were about 55 on FY2025 derived cost of sales.

Trend commentary. Returns are high and stable (underlying ROIC around 19%) because Unilever operates with structurally negative working capital and a large base of acquired intangibles. Liquidity ratios below 1.0x are typical for large FMCG companies with strong supplier financing and are not a concern given $5.2bn and €2.6bn of undrawn 364-day facilities, plus a further €2.0bn signed in June 2026. Leverage is at the top of the "around 2x" target range; the $15.7bn cash from McCormick (≈€13.7bn) is earmarked for separation costs, debt reduction and €6bn of buybacks over 2026–2029.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Turnover (EUR Mn)

52,44460,07359,60460,76150,503

Underlying sales growth (%)

4.59.07.04.23.5

Underlying EBITDA (EUR Mn)

11,38211,40811,51012,80311,394

Total net profit incl. discontinued (EUR Mn)

6,6218,2697,1376,36910,011

Net profit attributable to shareholders (EUR Mn)

6,0497,6426,4875,7449,469

Diluted EPS as reported (EUR)

2.332.982.562.292.59

Dividends declared per share (EUR)

1.70721.70721.70721.75881.8248

Free cash flow (EUR Mn)

6,4005,2007,1006,9005,921

Net debt (EUR Mn)

26,25724,11324,43424,51923,076

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Cash Flow and Margin Analysis (%)

MetricFY2023FY2024FY2025

Turnover (EUR Mn)

51,70052,47950,503

Underlying volume growth (%)

1.13.11.5

Underlying price growth (%)

6.51.22.0

Underlying operating margin (%)

17.619.420.0

Operating margin (%)

17.416.817.9

Cash flow from operating activities (EUR Mn)

10,30010,91310,772

Free cash flow (EUR Mn)

6,4006,3045,921

Margin Analysis (%) and Income Statement

MetricFY2024FY2025

Gross margin (%)

46.746.9

Gross profit — derived (EUR Mn)

24,50823,686

Brand & marketing investment (% of turnover)

16.016.1

Underlying operating profit (EUR Mn)

10,19810,084

Operating profit (EUR Mn)

8,8299,037

EBITDA reported (EUR Mn)

10,06510,347

Underlying EBITDA (EUR Mn)

11,43411,394

Profit before tax (EUR Mn)

8,3718,693

Net profit, continuing (EUR Mn)

6,0396,213

Net profit attributable, continuing (EUR Mn)

5,4305,682

Diluted EPS continuing, consolidation-adjusted (EUR)

2.442.59

Underlying EPS diluted (EUR)

3.063.08

Underlying effective tax rate (%)

25.925.7

Net margin, continuing (%)

11.512.3

Underlying EBITDA margin (%)

21.822.6

Balance Sheet

Metric (EUR Mn)FY2023FY2024FY2025

Total assets

75,26679,75070,471

Total equity

20,76422,55517,587

Net debt

24,43424,51923,076

Balance Sheet (FY2024–H1 2026)

Metric (EUR Mn)FY2024FY2025H1 2026

Cash and cash equivalents

6,1363,9414,726

Current financial liabilities (short-term debt)

6,9872,5828,142

Non-current financial liabilities (long-term debt)

25,06625,69623,968

Total financial liabilities

32,05328,27832,110

Net debt

24,51923,07625,961

Goodwill

22,31117,70918,515

Intangible assets

18,59017,05517,560

Goodwill and intangibles

40,90134,76436,075

Current assets

19,19417,06621,389

Current liabilities

25,23421,66228,891

Working capital (current assets less current liabilities)

-6,040-4,596-7,502

Shareholders' equity

19,99015,53016,194

Pension surplus, net

3,0003,5003,700

Cash Flow

Metric (EUR Mn)FY2024FY2025H1 2025H1 2026

Cash flow from operating activities (pre-tax, continuing)

10,91310,7723,1474,347

Income tax paid

2,4522,7201,1281,770

Net capital expenditure

1,5991,465480599

Net interest paid

559666455429

Free cash flow

6,3045,9211,0841,549

Dividends paid on ordinary capital

4,3194,4532,2342,033

Share repurchases

1,5081,5101,5101,507

Acquisitions of businesses (cash)

7341,674458867

Disposals of businesses (cash)

91010773206

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2024FY2025

ROE — attributable net profit / average shareholders' equity (%)

30.232.0

ROA — net profit / average total assets (%)

8.28.3

Underlying ROIC (company, %)

19.119.0

Current ratio (x)

0.760.79

Total financial liabilities / total equity (x)

1.421.61

Net debt / underlying EBITDA (x)

2.142.03

Interest coverage — operating profit / finance costs (x)

8.98.8

Interest coverage — UOP / net finance costs (x)

19.620.0

Asset turnover — turnover / average total assets (x)

0.680.67

Revenue by Region

Region (turnover, EUR Mn)FY2024FY2025

Asia Pacific Africa

23,44822,427

The Americas

19,60518,622

Europe

9,4269,454

Total

52,47950,503

Region (FY2025) Overview

Region (FY2025)Turnover change %USG %UVG %UPG %Currency %% of group

Asia Pacific Africa

-4.44.63.01.6-6.544

The Americas

-5.03.30.03.2-7.837

Europe

0.31.51.20.3-0.119

Revenue by Region (FY2025–H1 2026)

Cluster (turnover, EUR Mn)FY2025H1 2026

Emerging markets

30,00015,400

Developed markets

20,50010,200

North America

11,2005,700

Latin America

7,4004,000

Revenue by Region (%)

Cluster (USG %)FY2025H1 2026

Emerging markets

3.57.0

Developed markets

3.61.5

North America

5.32.7

Latin America

0.57.6

Asia Pacific Africa

4.67.3

Europe

1.5-0.9

Valuation Snapshot

MetricValue

Price, 25 Sep 2026 (LSE, pence)

4,664.5

2026 opening price (pence)

4,851.5

2026 YTD change (%)

-3.85

2026 high (pence)

5,526

2026 low (pence, as reported by aggregator; may reflect a data anomaly)

3,644

TSR over two years to end-2025 (%, company)

26.8

Peer average TSR over same period (%, company)

-8

Share price change since demerger to 2 March 2026 (%, company)

11.6

Valuation Multiples

MultipleUnileverBasis

P/E on FY2025 underlying EPS (€3.08)

≈ 17.4x

Price ≈ €53.7

P/E on FY2025 diluted continuing EPS (€2.59)

≈ 20.7x

—

EV/underlying EBITDA FY2025

≈ 12.4x

Market cap ≈ €115bn + net debt €26.0bn (H1 2026)

EV/Sales FY2025

≈ 2.8x

—

P/B

≈ 7.1x

Shareholders' equity €16.2bn (H1 2026)

Source Details

SourceRating / targetDate

eToro average price target

4,300p–4,600p (varied across pages)

2026

Simply Wall St consensus target

£52.14 (range £40.87–£60.52 across snapshots)

2026

UBS (Guillaume Delmas)

Sell; 4,440p

20 Mar 2026

Berenberg

Downgraded to Hold; target raised to 5,840p

18 Feb 2026

Unilever-compiled consensus for FY2026 (pre-Q1)

USG 4.0%, UVG 2.1%, UOM 20.1%, EPS growth 3.4%

Q1 2026

Per-Share Data and Dividends & Capital Returns

MetricFY2021FY2022FY2023FY2024FY2025

Dividends declared per share (EUR)

1.70721.70721.70721.75881.8248

Dividends paid on ordinary capital (EUR Mn)

———4,3194,453

Capital Programmes

ProgrammeSizeExecutedShares repurchased
2,024

€1.5bn

2,024

Not compiled

2,025

€1.5bn

13 Feb–30 May 2025

27,815,955
2,026

€1.5bn

30 Apr–5 Jun 2026

30,703,780

2026–2029 plan

€6.0bn total (incl. 2026 programme)

Ongoing

—

Credit Ratings

AgencyLong-termShort-termOutlook

S&P

A+

A-1

Negative

Moody's

A1

P-1

Stable

Morningstar DBRS

——

Stable

Maturity Year Details

Maturity yearNotable instruments disclosed (selection)
2026

2.0% and 7.25% US notes; €500m 0.75% note repaid February 2026

2027

2.9% and 4.25% notes; €600m floating-rate notes (September 2027)

2028

3.5%, 4.875% and 6.625% notes

2029

2.125% notes

2030

1.375% notes; €700m 2.75% (May 2030)

2031

4.75% and 1.75% notes

2032

5.9% notes; €850m 2.875% (October 2032)

2033–2035

5.0% (2033), 4.625% (2034), $150m 4.824% and €800m 3.375% (2035)

2037

€800m 3.50% (October 2037)

2051 and 2097

2.625% (2051); 5.600% (2097)

Analyst Conclusions

Management guidance (upgraded 28 July 2026)

MetricFY2026 guidance
Underlying sales growthWithin 4%–6% multi-year range (previously bottom end)
Underlying volume growthAround 3% (previously at least 2%)
H2 2026 USG4%–5%, led by pricing
Underlying operating marginModest improvement versus 20.0%
H2 gross marginBroadly similar to H1 (46.8%)
RestructuringAbout 1.0% of turnover
Underlying effective tax rateAround 26%
Net finance costsBelow 3% of average net debt
Cash conversionAround 100%
Net debt / underlying EBITDAAround 2x by year-end

Consensus growth expectations

Pre-Q1 company-compiled consensus expected FY2026 USG of 4.0%, UOM of 20.1% and EPS growth of 3.4%. MarketScreener's aggregated forecasts show turnover of about €51.8bn (FY2026) rising to about €55.5bn (FY2028), with net debt drifting towards €22bn by FY2028.

Bull case

  1. Volume inflection is real and broad-based. Q2 2026 volume growth of 5.5%, with all four Business Groups growing volume and emerging markets at +7.4% volume, suggests improved execution rather than an easy comparison.

  2. Pure-play HPC plus buybacks equals a re-rating. Post-McCormick, Unilever becomes a roughly €39bn HPC company with the Foods cash funding €6bn of buybacks over 2026–2029; at about 17x underlying earnings, the shares trade at a discount to many US HPC peers.

  3. Margin structure keeps improving. The €800m productivity programme is complete, overheads improved 70bps in H1 2026 and BMI is already at a competitive 16.1%, leaving gross-margin and mix gains to flow through.

Bear case

  1. Pricing-led H2 and commodity squeeze. H2 2026 growth is guided to be led by price as commodity costs rise; gross margin already fell 70bps in H1, and volumes could soften as prices land.

  2. Loss of the best-margin business. Foods earned a 22.6–23.3% underlying operating margin; removing it mechanically dilutes group margin and earnings (UBS flagged dilution), and Unilever's residual 9.9% stake carries market risk.

  3. Developed-market and Wellbeing deceleration. North America slowed to 2.7% USG in H1 2026, Europe is declining and Wellbeing has moderated, which matters because the US is a designated anchor geography and prestige/Wellbeing are the premium growth engines.

Catalysts and monitorables (next 12 months)

Date / windowCatalystWhat to monitor
28 Oct 2026Q3 2026 trading statementPrice/volume balance as pricing lands; Brazil Vinhedo impact; Foods recovery
4 Nov 2026Investor Event, New YorkPure-play HPC targets, US strategy, possible updated medium-term framework
Q4 2026Brazil tax reformRetailer destocking ahead of 2027 price reductions
H1 2027McCormick shareholder vote; antitrust and works-council processesTiming, any remedies, final cash adjustments
By mid-2027Foods completionRe-presentation of Foods as discontinued; use of $15.7bn cash
OngoingTMICC stake selldownProceeds and timing of the 19.85% stake disposal
Feb 2027FY2026 resultsDelivery against upgraded guidance; 2027 outlook; buyback size
OngoingLeverage and ratingsS&P negative outlook resolution

Analyst verdict

Unilever in late 2026 is a markedly better-run company than the one that drifted through 2019–2023. The evidence is no longer anecdotal: twelve-plus consecutive quarters of positive volume, a record 20% underlying operating margin on a continuing basis, the productivity programme delivered ahead of plan, and an upgraded FY2026 outlook built on the best volume quarter in more than a decade. Management has also shown it can execute complex portfolio surgery, completing the Ice Cream demerger on schedule and agreeing a tax-efficient Reverse Morris Trust for Foods within a year of taking office.

The strategic destination — a focused Beauty, Wellbeing, Personal Care and Home Care company anchored in the US and India, with 60% emerging-market exposure — is the right one, and it is the configuration most likely to narrow the valuation gap with US HPC peers. The cash from McCormick provides unusual flexibility: debt reduction, €6bn of buybacks and room for bolt-ons such as Dr. Squatch and Grüns.

Three issues temper the enthusiasm. First, the post-Foods company will be structurally lower-margin, with Home Care still below 16% and dependent on petrochemical inputs at a time of commodity inflation. Second, reported earnings remain hostage to emerging-market currencies, which have consumed almost all constant-currency EPS growth in recent years. Third, the next twelve months are execution-dense: a pricing-led second half, Brazilian regulatory and tax disruption, the TMICC services agreement, the Foods carve-out and an investor day that must set credible pure-play targets.

On balance, the investment case is improving but not yet de-risked. Unilever merits a constructive-but-selective stance: the volume-led recovery and capital-return programme support upside, while the key monitorables are H2 price-volume balance, North American Wellbeing trends and on-time, on-terms completion of the McCormick combination. Delivery on those three points would likely be the trigger for a sustained re-rating.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / background (as disclosed)

Fernando Fernandez

Chief Executive Officer, Executive Director

CEO since 1 March 2025; CFO January 2024–February 2025; previously President Beauty & Wellbeing, head of Latin America, Unilever Brazil (2011–2019), Unilever Philippines, Global Hair Care. Age reported as 59 (Simply Wall St)

Srinivas Phatak

Chief Financial Officer, Executive Director

Acting CFO from March 2025; the 2025 Directors' Remuneration Report covers his Executive Director period from 16 September 2025; previously in senior finance leadership at Hindustan Unilever

Eduardo Campanella

Business Group President, Home Care

President Home Care since late 2023; previously Chief Marketing Officer Home Care

Fabian Garcia

Business Group President, Personal Care

In role since the 2022 Business Group model

Heiko Schipper

Business Group President, Foods

Leads Foods through the McCormick separation

Reginaldo Ecclissato

President, 1 Unilever Markets

Leads the One Unilever cluster of small and mid-sized markets

Priya Nair

CEO & Managing Director, Hindustan Unilever

CEO of HUL since 1 August 2025 (five-year term); first woman to lead HUL; previously President Beauty & Wellbeing (2023–2025); joined HUL in 1995

Prakash Kakkad

Chief Legal Officer and Group Company Secretary

Succeeded Maria Varsellona

Mairéad Nayager

Chief People Officer

Leads the "Play to Win" people strategy

Richard Slater

Chief Research & Development Officer

Leads global R&D

Willem Uijen

Chief Supply Chain and Operations Officer

Leads the supply chain

Board of Directors

NameRoleBackground (summary)

Ian Meakins

Chair, Non-Executive Director

Chair by 2024; former CEO of Wolseley/Ferguson; extensive FTSE chair experience

Susan Kilsby

Vice Chair, Senior Independent Director, Chair of the Remuneration Committee

Took both roles at the 2025 AGM; former chair of Shire

Fernando Fernandez

CEO, Executive Director

See above

Srinivas Phatak

CFO, Executive Director

See above

Adrian Hennah

Independent Non-Executive Director

Former CFO of Reckitt Benckiser

Ruby Lu

Independent Non-Executive Director

Venture-capital investor (Asia, technology/consumer)

Judith McKenna

Independent Non-Executive Director

Former President and CEO, Walmart International

Nelson Peltz

Non-Executive Director

Founding Partner and CEO of Trian Fund Management; joined in 2022

Benoît Potier

Independent Non-Executive Director

Former Chairman and CEO of Air Liquide; joined 2025

Zoe Yujnovich

Independent Non-Executive Director

Former senior executive at Shell; joined 2025

Directors' Remuneration

ItemFernando FernandezSrinivas Phatak

Fixed pay paid in 2025 (EUR)

1,710,521342,708

Annual fixed pay rate as CEO (EUR)

1,800,000—

Bonus deferred into shares (EUR)

464,23776,287

2025 single figure of total remuneration (EUR)

≈ 5.6m (third-party compilation; verify against DRR p.96)

—

Board & Management Changes

DateChange

25 February 2025

Hein Schumacher to step down; Fernando Fernandez named CEO effective 1 March 2025; Srinivas Phatak named acting CFO

April 2025

Benoît Potier and Zoe Yujnovich elected to the Board; Susan Kilsby becomes Vice Chair and SID

10 July 2025

Priya Nair named HUL CEO & MD effective 1 August 2025, succeeding Rohit Jawa

September 2025

Srinivas Phatak formally joins the Board as CFO

1 January 2026

At HUL, Vandana Suri becomes Executive Director Home Care; Srinandan Sundaram becomes CEO of Unilever International

July 2026

Belén Garijo López withdraws from planned NED appointment

Competitive Landscape

Competitors by Segment

SegmentPrincipal competitors

Beauty & Wellbeing

L'Oréal, Procter & Gamble, Estée Lauder, Beiersdorf, Kenvue, Shiseido, Kao, Haleon (VMS), Church & Dwight (VMS), Bayer consumer health

Personal Care

Procter & Gamble, Colgate-Palmolive, Beiersdorf, Henkel, Edgewell, Church & Dwight, Kenvue, Haleon (oral care)

Home Care

Procter & Gamble, Henkel, Reckitt, Colgate-Palmolive, Clorox, Kao, strong local players (e.g., Nirma in India; Ypê in Brazil)

Foods

Nestlé, Kraft Heinz, McCormick (future partner), Ajinomoto, Mars Food, Campbell's, Lee Kum Kee, local condiment makers

Peer Comparison FY2025

CompanyLatest FY revenue (approx.)Organic growth (approx.)Margin (approx.)R&D intensity

Unilever (FY2025, continuing)

€50.5bn

3.5% USG

20.0% UOM

1.7%

Procter & Gamble (FY to June 2025)

≈ $84bn

≈ 2% organic

≈ 24% operating margin

—

L'Oréal (FY2024)

≈ €43.5bn

≈ 5% like-for-like

≈ 20% operating margin

—

Colgate-Palmolive (FY2024)

≈ $20bn

≈ 8% organic

——

Nestlé (FY2024)

≈ CHF 91bn

≈ 2% organic

≈ 17% UTOP margin

—

Henkel (FY2024)

≈ €21.6bn

≈ 2.6% organic

≈ 14% adjusted EBIT

—

Reckitt (FY2024)

≈ £14.2bn

≈ 1.4% like-for-like

——

Beiersdorf (FY2024)

≈ €9.9bn

≈ 6.5% organic

——

Kenvue (FY2024)

≈ $15.5bn

———

McCormick (FY2025)

≈ $7bn (company description)

———

Company Snapshot

$56,936.9M

Revenue

96,000

Employees

1929

Founded

Victoria Embankment, United Kingdom

Headquarters

SWOT Analysis

Strengths

  • Record profitability: underlying operating margin reached 20.0% in FY2025 (+60bps) and 20.3% in H1 2026 (FY2025 and H1 2026 Results).
  • Volume-led momentum: Q2 2026 delivered 5.5% volume growth, the best volume quarter in over a decade; FY2025 marked 12 consecutive quarters of positive volume.
  • Power Brand concentration: 30 Power Brands make up 78% of turnover and grew 6.0% USG with 5.4% volume in H1 2026.
  • Emerging-market franchise: emerging markets were 60% of H1 2026 turnover and grew 7.0%, led by India (+8%) and Latin America (+7.6%).
  • Cash generation and returns: FY2025 free cash flow of €5.9bn at 100% cash conversion; underlying ROIC of 19.0%; €6.0bn returned to shareholders in 2025.
  • Execution recognition: second overall in the US Advantage Group retailer survey and number one in Foods and Personal Care (Form 20-F 2025).

Weaknesses

  • Currency drag on reported results: FY2025 turnover fell 3.8% despite 3.5% USG because of a 5.9% currency headwind; underlying EPS rose only 0.7%.
  • Home Care margin gap: Home Care's underlying operating margin of 14.9% (FY2025) is far below Personal Care and Foods (22.6% each).
  • Leverage near the top of target: net debt/underlying EBITDA rose to 2.3x at H1 2026, above the around-2x target.
  • European stagnation: Europe declined 0.9% USG in H1 2026 and Germany and Eastern Europe were weak.
  • Governance and pay friction: the 2024 Remuneration Report received 27.71% votes against at the 2025 AGM.
  • History of underperformance: the Chair acknowledged that TSR significantly lagged peers in the five years to end-2023.

Opportunities

  • Pure-play HPC re-rating: completion of the McCormick deal would create a focused HPC company with about €39bn of pro-forma revenue, potentially closing the valuation discount to US peers.
  • Buyback firepower: $15.7bn in cash supports €6bn of buybacks over 2026–2029.
  • India: HUL reached record Home Care and hair care market shares in Q2 2026; India is designated an anchor geography.
  • Wellbeing and GLP-1 adjacency: Nutrafol turnover has tripled since 2022 and is being positioned as a complement to GLP-1 treatment; Grüns adds greens supplements.
  • Premium platform roll-outs: Wonder Wash (30 markets), Whole Body Deodorant (15 markets) and Cif Infinite Clean (five markets) have runway for further expansion.
  • AI-led productivity: AI simulations, digital twins and AI content studios are already reducing time-to-market and content costs (Form 20-F 2025).

Threats

  • Deal execution risk: McCormick completion depends on its shareholder vote, antitrust clearance and works-council consultation; slippage beyond mid-2027 is possible.
  • Commodity inflation: gross margin fell 70bps to 46.8% in H1 2026 on commodity costs, particularly in Home Care.
  • Regulatory and quality incidents: Anvisa suspended production at the Vinhedo plant on 2 September 2026; legacy-product litigation charges recur in non-underlying items.
  • Category slowdown in developed markets: management cited slowing US and European markets in Q4 2025 and H1 2026; North America USG slowed from 5.3% (FY2025) to 2.7% (H1 2026).
  • Competitive intensity in US condiments and Wellbeing: share loss in premium and avocado mayonnaise; Wellbeing market softening in Q4 2025.
  • Brazil tax reform: expected price reductions from 2027 could lead to temporary retailer destocking in Q4 2026 (H1 2026 Results).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Apr 2025Wild acquired; Conimex sold to Paulig; Nutrafol ownership taken to 100%Premiumisation and Foods pruning
21 Apr 2025HUL completes 90.5% acquisition of MinimalistPremium beauty in India
24 Apr 2025Q1 2025 trading statement; about 6,000 roles already removed under productivity programme; tariff impact described as limitedCost delivery on track
30 Apr 2025AGM: Remuneration Report passes with only 72.29% supportGovernance pressure on pay
30 May 2025€1.5bn buyback completed (27.8m shares)Capital returns
Jun 2025Dr. Squatch acquisition announcedLargest bolt-on of 2025
1 Jul 2025Ice Cream operates as a standalone business internally ahead of listingSeparation milestone
10 Jul 2025Priya Nair named HUL CEO effective 1 August 2025Leadership in anchor market
31 Jul 2025H1 2025 results (incl. Ice Cream): turnover €30.1bn, net profit down about 5%Currency pressure
2 Sep 2025Dr. Squatch completed (€1,243m)US premium men's care
Sep 2025The Vegetarian Butcher sale completed; Srinivas Phatak joins Board as CFOPortfolio and leadership
Oct 2025Q3 2025 trading statement: all Business Groups above 3% USG; India affected by GST reform; restructuring guidance cut to about 1.2% of turnoverOutlook reconfirmed
Nov 2025Kate Somerville sale completedPrestige pruning
6–8 Dec 2025Ice Cream demerger; TMICC lists at ≈ €7.9bn market value; Unilever shares fall 4–5% on first day; 8-for-9 share consolidationTransformational portfolio change
Dec 2025HUL management changes announced (effective 1 January 2026)India leadership
Jan 2026Agreements to sell Indonesia tea and Colombia/Ecuador Home Care businessesPortfolio focus
12 Feb 2026FY2025 results: USG 3.5%, UOM 20.0%, new €1.5bn buyback, dividend +3%Margin record
Feb 2026Graze sale completed; Berenberg downgrades to Hold (target 5,840p)Analyst caution
12 Mar 2026Form 20-F 2025 filed with the SECAnnual filing
Mar 2026Indonesia tea (Sariwangi) sale completedDisposal
20 Mar 2026Unilever confirms talks with McCormick after media reports; UBS reiterates Sell (4,440p)Deal speculation
31 Mar 2026Foods combination with McCormick announced; Unilever shares fall about 5%Path to pure-play HPC; valuation below some analyst estimates (>$48bn)
30 Apr 2026Q1 2026: USG 3.8%, UVG 2.9%; buyback commencesVolume momentum
Apr 2026Kwality Wall's India stake and Portugal ice cream JV sold to TMICCIce Cream exit completed
May 2026Belén Garijo appointed CEO of Sanofi (later withdraws from Unilever Board appointment)Board renewal setback
5 Jun 2026€1.5bn buyback completed (30.7m shares)Capital returns
Jun 2026Grüns acquisition completed; additional €2.0bn credit facilities signedWellbeing expansion; liquidity
Jun–Jul 2026FIFA World Cup 2026 activationsQ2 volume support, promotional cost
23 Jul 2026McCormick announces combined operating model, executive team and London secondary listingDeal on track
28 Jul 2026H1 2026: USG 4.8%, Q2 USG 5.8% with 5.5% volume (best volume quarter in over a decade); FY2026 volume guidance raised to about 3%Outlook upgrade
2 Sep 2026Brazil's Anvisa suspends cleaning-product manufacturing at the Vinhedo (SP) plant after finding Good Manufacturing Practice failures; no recall ordered and no microbiological contamination foundOperational/regulatory risk in Home Care's second-largest market
4 Sep 2026Hindustan Unilever investor event (Mumbai)India strategy update
9 Sep 2026Further McCormick Form 425 communication filedDeal process
28 Oct 2026 (scheduled)Q3 2026 trading statementNext catalyst
4 Nov 2026 (scheduled)Unilever Investor Event (New York)Pure-play HPC equity story

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Revenue by Region (FY2024–FY2025): Total fell from EUR 52,479 Mn in FY2024 to EUR 50,503 Mn in FY2025.
Unilever Plc — Revenue by Region (FY2024–FY2025)
Series (EUR Mn)FY2024FY2025
Total52,47950,503
Asia Pacific Africa23,44822,427
The Americas19,60518,622
Europe9,4269,454

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Unilever, 2025 Full Year Results (12 February 2026) (unilever.com)
  2. Unilever, 2025 Full Year Results highlights (unilever.com)
  3. Unilever, Annual Report on Form 20-F 2025 (filed 12 March 2026) (sec.gov)
  4. Unilever, 2026 First Half Results (28 July 2026), via Investegate (investegate.co.uk)
  5. Unilever, Q1 2026 Trading Statement (30 April 2026) (investegate.co.uk)
  6. Unilever, Q1 2026 overview (unilever.com)
  7. Unilever, Q3 2025 Trading Statement (FCA NSM) (data.fca.org.uk)
  8. Unilever, 2023 Full Year Results highlights (unilever.com)
  9. Unilever, Our leadership (unilever.com)
  10. Unilever, Debt investors (unilever.com)
  11. Unilever, Dividend calculator and history (unilever.com)
  12. Unilever, Directors' Remuneration Report 2025 (unilever.com)
  13. SEC 6-K, CEO succession (25 February 2025) (sec.gov)
  14. SEC 6-K, 2025 AGM results (sec.gov)
  15. Cleary Gottlieb, McCormick/Unilever Foods (clearygottlieb.com)
  16. Baking Business, McCormick deal terms (bakingbusiness.com)
  17. Food & Drink Technology, deal summary (foodanddrinktechnology.com)
  18. McCormick, combined-company update (23 July 2026) (ir.mccormick.com)
  19. Hargreaves Lansdown, deal reaction (hl.co.uk)
  20. Mercado & Consumo / Band, Anvisa Vinhedo suspension (2 September 2026) (mercadoeconsumo.com.br)
  21. Hindustan Unilever, management changes (hul.co.in)
  22. People Matters, Priya Nair appointment (peoplematters.in)
  23. Reuters via Yahoo Finance, Ice Cream separation and job cuts (March 2024) (finance.yahoo.com)
  24. Malay Mail (Reuters), TMICC listing (malaymail.com)
  25. InvestSMART, ULVR price history (investsmart.com.au)
  26. eToro, ULVR statistics (etoro.com)
  27. MarketScreener, Unilever financials (uk.marketscreener.com)
  28. finanzen.at (dpa-AFX), UBS rating (finanzen.at)
  29. Simply Wall St, management and consensus (simplywall.st)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.